DK171679B1 - Fremgangsmåde til fraskillelse af aktiveret humant protein C - Google Patents

Fremgangsmåde til fraskillelse af aktiveret humant protein C Download PDF

Info

Publication number
DK171679B1
DK171679B1 DK209288A DK209288A DK171679B1 DK 171679 B1 DK171679 B1 DK 171679B1 DK 209288 A DK209288 A DK 209288A DK 209288 A DK209288 A DK 209288A DK 171679 B1 DK171679 B1 DK 171679B1
Authority
DK
Denmark
Prior art keywords
human protein
antibody
activated
activated human
protein
Prior art date
Application number
DK209288A
Other languages
Danish (da)
English (en)
Other versions
DK209288A (da
DK209288D0 (da
Inventor
Kenji Wakabayashi
Yoshihiko Sumi
Yataro Ichikawa
Yoichi Sakata
Nobuo Aoki
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of DK209288D0 publication Critical patent/DK209288D0/da
Publication of DK209288A publication Critical patent/DK209288A/da
Application granted granted Critical
Publication of DK171679B1 publication Critical patent/DK171679B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK209288A 1987-04-17 1988-04-15 Fremgangsmåde til fraskillelse af aktiveret humant protein C DK171679B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9337787 1987-04-17
JP9337787 1987-04-17

Publications (3)

Publication Number Publication Date
DK209288D0 DK209288D0 (da) 1988-04-15
DK209288A DK209288A (da) 1988-10-18
DK171679B1 true DK171679B1 (da) 1997-03-10

Family

ID=14080613

Family Applications (1)

Application Number Title Priority Date Filing Date
DK209288A DK171679B1 (da) 1987-04-17 1988-04-15 Fremgangsmåde til fraskillelse af aktiveret humant protein C

Country Status (5)

Country Link
EP (1) EP0287028B1 (no)
KR (1) KR940010023B1 (no)
DE (1) DE3882411T2 (no)
DK (1) DK171679B1 (no)
NO (1) NO174056C (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2645865B1 (fr) * 1989-04-12 1991-07-12 Fondation Nale Transfusion San Procede de preparation de la proteine c activee et solution de proteine c activee ainsi obtenue
FR2658517B2 (fr) * 1989-04-12 1992-06-19 Fondation Nale Transfusion San Preparation de la proteine c activee et solution de proteine c activee ainsi obtenue.
AT395596B (de) * 1991-06-20 1993-01-25 Immuno Ag Verfahren zur herstellung von aktiviertem protein c
AT402263B (de) * 1991-06-20 1997-03-25 Immuno Ag Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
EP1322749B1 (en) 2000-10-02 2010-04-14 Oklahoma Medical Research Foundation Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor
TW200407335A (en) * 2002-07-22 2004-05-16 Chugai Pharmaceutical Co Ltd Non-neutralizing antibody to inhibit the inactivation of activated protein C

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485711D1 (de) * 1983-03-04 1992-06-17 Scripps Clinic Res Immunoadsorbens und verfahren zur zurueckgewinnung von vitamin-k-abhaengigen proteinen mittels dieses adsorbens.
GB8327860D0 (en) * 1983-10-18 1983-11-16 Fujisawa Pharmaceutical Co Monoclonal antiprotein c antibody
JPH0619352B2 (ja) * 1985-06-10 1994-03-16 帝人株式会社 ヒト・プロテインｃの測定方法

Also Published As

Publication number Publication date
EP0287028A3 (en) 1990-09-26
EP0287028A2 (en) 1988-10-19
KR880012752A (ko) 1988-11-29
NO881650L (no) 1988-10-18
DK209288A (da) 1988-10-18
NO881650D0 (no) 1988-04-15
DE3882411T2 (de) 1993-12-16
DE3882411D1 (de) 1993-08-26
KR940010023B1 (ko) 1994-10-20
NO174056C (no) 1994-03-09
NO174056B (no) 1993-11-29
DK209288D0 (da) 1988-04-15
EP0287028B1 (en) 1993-07-21

Similar Documents

Publication Publication Date Title
US4902614A (en) Monoclonal antibody to human protein C
CA1315716C (en) Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same
CA1341506C (en) Factor viii coagulant polypeptides and monoclonal antibodies to them
JPH0636741B2 (ja) ヒト・プロテインｃの分離方法
US5279956A (en) Activated protein C polypeptides and anti-peptide antibodies, diagnostic methods and systems for inhibiting activated protein C
DK171679B1 (da) Fremgangsmåde til fraskillelse af aktiveret humant protein C
CN102532316B (zh) 一种抗vWF单克隆抗体及其应用
CA2499926C (en) Antibody against von willebrand factor cleaving enzyme and assay system using the same
EP0159025B1 (en) Monoclonal antibody specific to human alpha2-plasmin
CA2519258A1 (en) Construct comprising region recognized by antibody against von willebrand factor-specific cleaving protease
DK171836B1 (da) Monoklonalt antistof mod protein C, hybridom, der producerer antistoffet, fremgangsmåde til måling af humant protein C med et Gla-område samt fremgangsmåde til udvinding af humant protein C med et Gla-område
EP0271810A2 (en) Immunological determination of free human protein s and c4bp-protein s complex
USH1148H (en) Method of separating activated human protein C
JPH05304953A (ja) 抗トロンビン結合性物質モノクローナル抗体を産生するハイブリドーマ
AU649868B2 (en) A process for the purification of factor XIII, monoclonal antibodies against factor XIIIA, the preparation and use thereof
JPH0735340B2 (ja) 血栓溶解促進剤
HUT55445A (en) Process for producing hibride monoclonal antibodies
CN116444674B (zh) 一种抗血管性血友病因子抗体及其应用
Hoad et al. Characterisation of monoclonal antibodies to human factor X/Xa initial observations with a quantitative ELISA procedure
CA2031504C (en) Monoclonal antibodies to c-reactive protein
JP4612922B2 (ja) 新規のモノクローナル抗体並びにｅ−Ｄモノマー、ｅ−Ｄダイマー、及びｅ−ＤＤ／Ｅ複合体の免疫学的分析方法
JPS61221128A (ja) プラスミノ−ゲン活性化因子に対するモノクロ−ナル抗体とその調製方法及び該モノクロ−ナル抗体の使用方法
JPH03200066A (ja) 活性化ヒトプロテインｃの測定方法
Herion et al. Monoclonal antibodies against plasma protease inhibitors: production and characterization of 15 monoclonal antibodies against human antithrombin III. Relation between antigenic determinants and functional sites of antithrombin III
JPS63148994A (ja) ヒト・プロテインｓに対するモノクローナル抗体

Legal Events

Date Code Title Description
PUP Patent expired